Elona: An Open-Label, Phase 1B-2 Study Of Elacestrant, In Combination With Onapristone In Patients With Estrogen Receptor-Positive, Progesterone Receptor-Positive, Her2-Negative Advanced Or Metastatic Breast Cancer
Elacestrant;Onapristone
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Elona: An Open-Label, Phase 1B-2 Study Of Elacestrant, In Combination With Onapristone In Patients With Estrogen Receptor-Positive, Progesterone Receptor-Positive, Her2-Negative Advanced Or Metastatic Breast Cancer ### Output: Elacestrant;Onapristone